Jeanne Louise Calment from France was the oldest person to grace this Earth, living a full life until 122 years of age . She continuously exercised, taking up fencing in her 80s and cycling in her 100s. She claimed to have achieved such a long life through olive oil, port, and chocolate.
There are many speculations as to why she lived so long, from inherited traits to a hypothesis that she may have faked her mother’s identity, which is buttressed by an analysis of facial features and a plausible reason for the switch . However, assuming that she is truly 122 years old, her long survival was likely due to her exercise, eating habits, and inherited long lifespan .
While this is an interesting thing to ponder, a more interesting question for us is ‘Why did she die at 122?’ The answer isn’t definite, but there are some speculations, particularly one that the problem didn’t lie within mobility, or habits; instead, it lied within her brain.
A gradual depletion
Dr. Mora Francisco theorizes that by 120 years of age, even if we suffer from no other age-related diseases, the number of synapses (connections between neurons) in the neocortex, a location in the brain that controls cognition and movement, decreases to that of people with Alzheimer’s disease .
Dr. Francisco’s paper states that this can actually lead to a form of dementia without the common indicators. Key differences in advanced age lie within calcium homeostasis in neurons and decreases in synaptic density (thereby causing a decrease in different types of matter such as grey matter) .
Calcium homeostasis seems to be increasingly dysregulated with age, caused by changes in the influx (redirection with age) to neurons. This adversely influences cell structure and many molecular pathways. 
In a study conducted in 2003, synaptic density was found to decrease in aged adults, resulting in lower neocortical density and the density of other affected areas within the brain . This is because neurons gain all their synapses by the age of one, and the amount declines from there.
Stress may seem pretty inconsequential as a contributor to brain aging; however, Harvard researchers found in a 2019 study that lower neural excitation leads to longer lifespan . They reported that it was caused by a gene regulator named ‘REST,’ which does its typical job during fetal development and is found to return to its post at an advanced age, in which it causes the brain to adapt to age. People who have higher levels of neural excitation have less of this regulator, as it suppresses genes involved in neural excitation.
Efforts to reverse the decline
Currently, there are multiple efforts to combat aging of the brain. Since it’s hard to get trials approved for brain aging, and the subject is very broad, the topic is being studied as its separate disorders, including Parkinson’s and various dementias.
For Parkinson’s, drugs to increase levels of dopamine in the brain have been proven effective in mice, such as through upregulating trace amine-associated receptor 5 (TAAR5). TAAR5 is shown to generally decline with age, so this study directly targets a side effect of aging .
To treat Alzheimer’s, Biogen is working on aducanumab, a drug that is intended to reduce beta amyloid in the brain . Beta amyloid builds up in the brain during Alzheimer’s, making this a direct effort against a disease mechanism. Age-related amyloid buildup is a normal occurrence and happens on a smaller scale for people without Alzheimer’s ; therefore, in lower doses, this could become useful as a treatment for brain aging.
There are many efforts being led on this front, and it is suspected that we will see new research coming out soon on these topics of interest.
We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.
All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.
CHOOSE AN AMOUNT TO
GIVE PER MONTH
 Robine, J.-M., Allard, M., Herrmann, F. R., & Jeune, B. (2019). The Real Facts Supporting Jeanne Calment as the Oldest Ever Human. The Journals of Gerontology: Series A, 74(Supplement_1), S13–S20. https://doi.org/10.1093/gerona/glz198
 Deigin, Y. (2019, March 1). Jeanne or Yvonne? New evidence in the Calment affair. Medium. https://yurideigin.medium.com/jeanne-or-yvonne-new-evidence-in-the-calment-affair-c35451f0d899
 Robin-Champigneul F. (2020). Jeanne Calment’s Unique 122-Year Life Span: Facts and Factors; Longevity History in Her Genealogical Tree. Rejuvenation research, 23(1), 19–47. https://doi.org/10.1089/rej.2019.2298.
 Mora F. (2013). Successful brain aging: plasticity, environmental enrichment, and lifestyle. Dialogues in clinical neuroscience, 15(1), 45–52.
 Mora, F., Segovia, G., & del Arco, A. (2007). Aging, plasticity and environmental enrichment: Structural changes and neurotransmitter dynamics in several areas of the brain. Brain Research Reviews, 55(1), 78–88. https://doi.org/10.1016/j.brainresrev.2007.03.011
 Toescu, E. C., Verkhratsky, A., & Landfield, P. W. (2004). Ca2+ regulation and gene expression in normal brain aging. Trends in Neurosciences, 27(10), 614–620. https://doi.org/10.1016/j.tins.2004.07.010
 Peter R., H. (1979). Synaptic density in human frontal cortex — Developmental changes and effects of aging. Brain Research, 163(2), 195–205. https://doi.org/10.1016/0006-8993(79)90349-4
 Zullo, J. M., Drake, D., Aron, L., O’Hern, P., Dhamne, S. C., Davidsohn, N., Mao, C.-A., Klein, W. H., Rotenberg, A., Bennett, D. A., Church, G. M., Colaiácovo, M. P., & Yankner, B. A. (2019). Regulation of lifespan by neural excitation and REST. Nature, 574(7778), 359–364. https://doi.org/10.1038/s41586-019-1647-8
 Efimova, E. V., Kozlova, A. A., Razenkova, V., Katolikova, N. V., Antonova, K. A., Sotnikova, T. D., Merkulyeva, N. S., Veshchitskii, A. S., Kalinina, D. S., Korzhevskii, D. E., Musienko, P. E., Kanov, E. V., & Gainetdinov, R. R. (2021). Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice. Neuropharmacology, 182, 108373. https://doi.org/10.1016/j.neuropharm.2020.108373
 Biogen. (n.d.). Alzheimer’s Disease. Retrieved November 18, 2020, from https://www.biogen.com/en_us/alzheimers-disease.html
 Rodrigue, K. M., Kennedy, K. M., & Park, D. C. (2009). Beta-Amyloid Deposition and the Aging Brain. Neuropsychology Review, 19(4), 436–450. https://doi.org/10.1007/s11065-009-9118-x